Kappa Light Chain

Kappa light chains are one of the two immunoglobulin light chains (κ and λ) synthesized by B lymphocytes and plasma cells. They circulate as part of intact immunoglobulins or as free kappa light chains (FLCs) in serum and urine.

1. Marker of Plasma Cell Dyscrasias

Excess κ light chain production suggests monoclonal plasma cell proliferation, including:

• κ-type multiple myeloma
• Light-chain (Bence Jones) myeloma
• Monoclonal gammopathy of undetermined significance (MGUS)
• Plasma cell leukemia
• AL amyloidosis (less common than λ)

➡️ A high κ:λ ratio is characteristic of κ-restricted monoclonal disease.

2. Diagnostic Value (Serum Free Light Chain Assay)

Normal κ:λ ratio: 0.26 – 1.65

Increased κ with high ratio → κ monoclonal gammopathy

Decreased ratio → λ excess

This test is especially useful when:

• No M-spike is seen on serum protein electrophoresis
• Disease secretes only light chains
• Early detection of relapse is required

3. Renal Significance

Free κ light chains are nephrotoxic and may cause:

Light chain cast nephropathy

Proximal tubular injury (Fanconi syndrome – more often κ)

Progressive renal impairment

They may be detected in urine as Bence Jones proteins.

4. Amyloidosis

κ light chains can form amyloid fibrils in AL amyloidosis, though λ chains are more common

Leads to organ dysfunction (kidney, heart, liver)

5. Monitoring Disease Activity & Prognosis

Declining κ FLC levels indicate response to therapy

Rising levels suggest disease progression or relapse

Very high κ levels, especially with renal failure, indicate poor prognosis

6. Polyclonal Elevation (Benign Conditions)

Balanced increases in κ (with normal κ:λ ratio) occur in:

• Chronic infections
• Autoimmune diseases
• Chronic kidney disease
• Inflammatory states

➡️ Reflects polyclonal immune activation, not malignancy.